Search
Menu
Channels
Search
New Retina Radio
05.08.24
What conclusions can be drawn from a cross-trial comparison of randomized clinical trials assessing the safety and efficacy of anti-VEGF agents used in the treatment of AMD and DME? Paul Hahn, MD, PhD, sits down with Durga Borkar, MD, MMCi, and Ted Leng, MD, to review a recent presentation by Dr. Leng on this topic, and to examine the clinical relevance of the study's findings. This editorially independent podcast is supported by Genentech.
View full description +
Subscribe
06.04.26
ARVO '26: DME Delphi Study and RHONE-XBaruch Kuppermann, MD, PhD; and Murtaza Adam, MD
Editorially independent content, supported by Genentech.
05.15.26
New Retina Radio Journal Club w/ VBS: Observation vs. Vitrectomy for FloatersKyle Kovacs, MD; Matthew Starr, MD; and Nita Valikodath, MD
Editorially Independent Content Supported by Genentech
05.11.26
The Fellow Eye: Episode 4David Fell, MD; Justin C. Muste, MD; Allen C. Ho, MD; and Curtis Heisel, MD, MBA
05.08.26
Extending Treatment Efficacy in Wet AMDLejla Vajzovic, MD; Robert L. Avery, MD; Carl D. Regillo, MD; and Durga S. Borkar, MD, MMCi
05.04.26
The Retina Roundup from Medical to SurgicalKatharine Talcott, MD, and Jorge Fortun, MD
Sponsored by Zeiss
04.15.26
Racial/Ethnic Disparities in TDR, DME, and Other Vision Threats in Patients With DRJordan Deaner, MD; Vaidehi Dedania, MD; and Rehan Hussain, MD
Editorially Independent Content Supported by Genentech
03.19.26
GLP-1 Use and AMD RiskBarton Blackorby, MD, Katharine Talcott, MD, and Hong-Uyen Hua, MD
Editorially Independent Content Supported by Genentech
03.16.26
Spotlight on UNITY® VCS: Intelligent FluidicsJay Sridhar, MD; Steve Charles, MD, FACS, FICS, FASRS; and Maria Berrocal, MD
Sponsored by Alcon
03.05.26
The Fellow Eye: Episode 3David Fell, MD; Justin C. Muste, MD; Danny Mammo, MD; and Sean Berkowitz, MD
02.24.26
Mentoring in Retina: Addressing Economic DiversityKatherine E. Talcott, MD; Yoshihiro Yonekawa, MD; and Adrienne W. Scott, MD
02.19.26
New Retina Radio Journal Club w/ VBS: Outcomes for PDR Patients LTFU for at Least 1 YearKyle Kovacs, MD; Matt Starr, MD; and Nita Valikodath, MD, MS
Editorially Independent Content Supported by Genentech
02.12.26
The Fellow Eye: Episode 2David Fell, MD; Justin Muste, MD; Joshua H. Uhr, MD; and Arnulfo Garza-Reyes, MD
02.05.26
The Race to Slow GA: A Retina Specialist in the Driver’s Seat of GA TreatmentNemo Patel, MD and Patrick Staropoli, MD
This episode is sponsored by Apellis Pharmaceuticals, which developed its content and compensated the speakers.
02.05.26
Practical Insights on Adopting FDA-Approved Treatments Into PracticeNemo Patel, MD; Danny Mammo, MD; and Matthew Donovan, MD
This episode is sponsored by Apellis Pharmaceuticals, which developed its content and compensated the speakers.
02.05.26
What I Wish I Knew: Insights From the Next Generation of Retina SpecialistsNemo Patel, MD; Sam Minaker, MD; and Has Al-khersan, MD
This episode is sponsored by Apellis Pharmaceuticals, which developed its content and compensated the speakers.
01.15.26
New Retina Radio Journal Club w/ VBS: Diagnosis Delays in Stargardt DiseaseAlexis Warren, MD; Jesse Sengillo, MD; and Sruthi Arepalli, MD
Sponsored by Genentech
12.18.25
New Retina Radio Journal Club w/ VBS: Assessing Surgical Competency Among Retina Fellows: Perspectives from Directors and GraduatesNikisha Kothari, MD; Jesse Sengillo, MD; and Nicholas Farber, MD
Editorially Independent Content Supported by Genentech
12.09.25
DME, DR, and Next-Generation TherapiesDavid Miller, MD; Esther Kim, MD; and Ehsan Rahimy, MD
Editorially independent content, supported by Regeneron.
12.09.25
Wet AMD and Next-Generation TherapiesDavid Miller, MD; Esther Kim, MD; and Ehsan Rahimy, MD
Editorially independent content, supported by Regeneron.
12.04.25
Retinal Fluid Fluctuation’s Impact on Long-Term Visual Acuity (Ep. 3 of 3)Jay Sridhar, MD; Durga Borkar, MD, MMCi; and Christina Weng, MD, MBA
Sponsored by EyePoint Pharmaceuticals
12.04.25
Retinal Fluid Fluctuation’s Impact on Long-Term Visual Acuity (Ep. 2 of 3)Jay Sridhar, MD; Maggie Runner, MD; and Veeral Sheth, MD, MBA
Sponsored by EyePoint Pharmaceuticals
12.04.25
Retinal Fluid Fluctuation’s Impact on Long-Term Visual Acuity (Ep. 1 of 3)Jay Sridhar, MD; Danny Mammo, MD; and David Sarraf, MD
Sponsored by EyePoint Pharmaceuticals
11.25.25
Global Discussions in GA: Educating Patients and Encouraging Follow-UpAnat Loewenstein, MD; Jordi Monés, MD, PhD; Sobha Sivaprasad, MD; and Giovanni Staurenghi, MD
Editorially independent content, supported by Astellas.
11.25.25
Global Discussions in GA: Referral Patterns and Fellow-Eye MonitoringAnat Loewenstein, MD; Jordi Monés, MD, PhD; Sobha Sivaprasad, MD; and Giovanni Staurenghi, MD
Editorially independent content, supported by Astellas.
11.21.25
Endophthalmitis Rates With and Without Antibiotic ProphylaxisSruthi Arepalli, MD; Jesse Sengillo, MD; and Alexis Warren, MD
Editorially Independent Content Support by Genentech
11.17.25
The Nuts and Bolts of GA Therapy: Wrapping Up the ConversationCharles Wykoff, MD, PhD; Sruthi Arepalli, MD; and Kenneth Fan, MD, MBA
Editorially independent content, supported by an educational grant from Apellis Pharmaceuticals.
11.13.25
AAO '25: GLP-1s and AMD, and Parity in Retina CareAleksandra Rachitskaya, MD; and Julia Haller, MD
Editorially independent content, supported by Genentech.
11.10.25
Late-Breaking Talks at AAO '25: Phase 3 for Uveitic Macular Edema and GATHER2 OLERahul Khurana, MD; and Arshad Khanani, MD, MA
Editorially independent content, supported by Genentech.
11.06.25
AAO '25: Dry AMD Pipeline and Oral Treatment for Stargardt DiseasePeter Kaiser, MD; and Michel Michaelides, MD
Editorially independent content, supported by Genentech.
11.03.25
The Nuts and Bolts of GA Therapy: The Discussions ContinueCharles Wykoff, MD, PhD; Hasenin Al-khersan, MD; and Nakul Singh, MD
Editorially independent content, supported by an educational grant from Apellis Pharmaceuticals.
10.23.25
Late-Breaking Talks at AAO '25: Gene Therapy for RP and NPDRAllen Ho, MD; and Charles Wykoff, MD, PhD
Editorially independent content, supported by Genentech.
10.10.25
New Retina Radio Journal Club w/ VBS: Time-Driven Cost Analysis of PRP: Dollars, Minutes, and Patient CareNiki Kothari, MD; Jesse Sengillo, MD; and Nicholas Farber, MD
Editorially Independent Content Supported by Genentech
10.09.25
The Nuts and Bolts of GA Therapy: The Opening SessionsCharles Wykoff, MD, PhD; with Maryam Ghiassi, MD, MHS, and Matthew Cunningham, MD
Editorially independent content, supported by an educational grant from Apellis Pharmaceuticals.
10.02.25
Keeping Patients at the Center of GA Therapy: Preserving Vision vs Restoring VisionJohn Kitchens, MD; Ferhina Ali, MD, MPH; Margaret Chang, MD, MS; and David Eichenbaum, MD
Editorially independent content, supported by Astellas Pharma.
10.02.25
Keeping Patients at the Center of GA Therapy: Dosing Schedules, AREDS Vitamins, and PhotobiomodulationJohn Kitchens, MD; Ferhina Ali, MD, MPH; Margaret Chang, MD, MS; and David Eichenbaum, MD
Editorially independent content, supported by Astellas Pharma.
10.02.25
Keeping Patients at the Center of GA Therapy: Patient Education and Setting ExpectationsJohn Kitchens, MD; Ferhina Ali, MD, MPH; Margaret Chang, MD, MS; and David Eichenbaum, MD
Editorially independent content, supported by Astellas Pharma.
10.02.25
Keeping Patients at the Center of GA Therapy: Social Impact and Early InterventionJohn Kitchens, MD; Ferhina Ali, MD, MPH; Margaret Chang, MD, MS; and David Eichenbaum, MD
Editorially independent content, supported by Astellas Pharma.
09.26.25
New Retina Radio Journal Club w/ VBS: Aflibercept 8 mg in nAMD: Outcomes After Switching From FaricimabBen Young, MD; Pheobe Mellen, MD; and Jordan Deaner, MD
Editorially Independent Content Supported by Genentech and Astellas.
09.04.25
ASRS '25: ReCLAIM-2 and Continuous Glucose Monitoring in NPDRDavid Lally, MD; and Ehsan Rahimy, MD
Editorially independent content, supported by Genentech
08.21.25
ASRS '25: PORTAL 5-year Data in Wet AMD, and Home OCT vs Human GradersJohn Kitchens, MD; Krishna Mukkamala, MD
Editorially independent content, supported by Genentech
08.13.25
New Retina Radio Journal Club w/ VBS: Obstructive Sleep Apnea and Diabetic RetinopathyLediana Goduni, MD, Alexis Warren, MD, and Joshua Uhr, MD
Editorially independent content sponsored by Genentech and Astellas
07.21.25
The State of Geographic Atrophy Around the Globe: Part 2 of 2Anat Loewenstein, MD; Paulo Eduardo Stanga, MD; Patricio G. Schlottmann, MD; Daniel Ting, MD, PhD
Editorially independent content, supported by Astellas
07.21.25
The State of Geographic Atrophy Around the Globe: Part 1 of 2Anat Loewenstein, MD; Paulo Eduardo Stanga, MD; Patricio G. Schlottmann, MD; Daniel Ting, MD, PhD
Editorially independent content, supported by Astellas
07.18.25
Diabetic Retinopathy Severity and Income StatusBen Young, MD; Phoebe Mellen, MD; and Jordan Deaner, MD
Editorially Independent Supported By Genentech and Neurotech.
07.07.25
GA in 2025: Conversion to Wet AMD and Educating Patients on the Value of Continuing TherapyJudy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD
Editorially independent content, supported by Apellis
07.07.25
GA in 2025: Dosing Regimens, Drug Selection, and Ideal CandidatesJudy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD
Editorially independent content, supported by Apellis
06.20.25
Photobiomodulation for Age-related Macular DegenerationModerator Barton Blackorby, MD; Hong-Uyen Hua, MD; and Louis Cai, MD
Editorially independent content, supported with advertising by Genentech.
06.12.25
Duke AVS Clips: PVR, DR, Imaging, and MTMJason Hsu, MD; Majda Hadziahmetovic, MD; Aleksandra Rachitskaya, MD; Gavin Tan, MD, PhD, FRCSed
Editorially independent content
06.09.25
Duke AVS Clips: Pediatrics, Anesthesia Trends, and AILejla Vajzovic, MD; Jason Fan, MD; Glen J. Jaffe, MD
Editorially independent content
06.05.25
Duke AVS Clips: Gene Therapy, RDs, IOLs, and PVDsAvni P. Finn, MD, MBA; Lejla Vajzovic, MD, MBA; David Zacks, MD, PhD; Dilraj S. Grewal, MD; Xi Chen, MD, PhD; Yuxi Zheng, MD; Durga Borkar, MD; and Yannek I. Leiderman, MD, PhD
Editorially independent content
05.29.25
ARVO '25: ISTH0036 in Wet AMD/DME, and New Photobiomodulation DataMarion Munk, MD, PhD; and Diana Do, MD
Editorially independent content, supported by Genentech
05.22.25
ARVO '25: Real-World Next-Gen Anti-VEGF Dosing and TKIs in the PipelineDavid Miller, MD; and Robert Wang, MD
Editorially independent content, supported by Genentech
05.16.25
GLP-1s and Risk of Age-Related Ocular DiseaseEditorially independent content, supported with advertising by Genentech and Astellas Pharmaceuticals INC.
05.07.25
Fellow Eye RRD Risk per IRIS RegistryBarton Blackorby, MD; Louis Cai, MD; and Hong-Uyen Hua, MD
Editorially independent content, supported with advertising by Genentech and Astellas Pharmaceuticals INC.
03.21.25
Rates of Ocular AEs After Faricimab InjectionMaura Di Nicola, MD; Sruthi Arepalli, MD; and Barton Blackorby, MD
Editorially independent content, supported with advertising by Genentech and Astellas Pharmaceuticals INC.
01.09.25
Using OCT Angiography to Distinguish RVO and RAOYasha Modi, MD, and Kat Talcott, MD,
Supported by Zeiss Professional Education
01.09.25
OCT Angiography in a Real-world CSR CaseYasha Modi, MD, and Kat Talcott, MD
Supported by Zeiss Professional Education
12.19.24
Switching from Aflibercept to Faricimab in Wet AMD PatientsBen Young, MD, MS; Lediana Goduni, MD; and Joshua Uhr, MD,
Editorially Independent content supported by Apellis.
12.12.24
GA Options in Clinical Therapy: Which Patients Are a Fit for GA Treatment?John Kitchens, MD; Saradha Chexal, MD; and Geeta Lalwani, MD
Editorially Independent content supported by Astellas.
12.05.24
AAO '24: Real-world PDR Treatment vs. Protocol S Guidelines, and Retinal Imaging for Alzheimer'sAdrienne Scott, MD; and Dilraj Grewal, MD
Editorially independent content supported by Genentech.
11.21.24
New Retina Radio Journal Club w/ VBS: Does Metformin Reduce AMD Risk?Moderator Rebecca Soares, MD; Matt Starr, MD; and Nikisha Kothari, MD
Editorially Independent Content Sponsored by Genentech
11.14.24
AAO '24 Late-Breakers: Preventing Fas Activation Prior to RRD Repair, and Phase 2/3 Data on an Oral Therapy for GADurga S. Borkar, MD, MMCi; and Alex Melamud, MD
Editorially independent content supported by Genentech.
11.07.24
AAO '24 Late-Breakers: ELEVATUM Study and Home OCT in Wet AMDJeremiah Brown, MD, MS; and Eric Schneider, MD
Editorially independent content supported by Genentech.
10.31.24
AAO '24: COVID and Retinal Disease, Plus the Latest on Step Therapy and Declining ReimbursementRahul Khurana, MD; and Paul Hahn, MD, PhD
Editorially independent content supported by Genentech.
10.28.24
GA Options in Clinical Therapy: Why Aren't Doctors Embracing Complement Inhibition?John Kitchens, MD, Miguel Busquets, MD, and Esther Kim, MD
Editorially Independent content supported by Astellas.
10.17.24
New Retina Radio Journal Club with VBS: Pre-treatment with Chlorhexidine vs. Povidone-Iodine in Endophthalmitis PreventionMaura Di Nicola, MD; Sruthi Arepalli, MD; and Barton Blackorby, MD
Editorially Independent content supported by Regeneron
10.09.24
Real-World Studies Reported in Lisbon: Untreated GA Progression and High-Dose Aflibercept in Wet AMD, DME, and DRTed Leng, MD; and Michael Klufas, MD
Editorially Independent content supported by Apellis.
09.17.24
New Retina Radio Journal Club w/ VBS: Risk of Death, Stroke, and MI After RAOKatherine Talcott, MD; Kyle Kovacs, MD; and Phoebe Mellen, MD
Editorially Independent content supported by Genentech.
09.05.24
ASRS ’24: C1q Inhibition and Metformin for AMDJoel Pearlman, MD, PhD; and Dimitra Skondra, MD
Editorially Independent content supported by Genentech.
08.29.24
New Retina Radio Journal Club with VBS: Switching to Faricimab in Wet AMD Patients With a History of Anti-VEGF TherapyBen Young, MD, MS; Lediana Goduni, MD; and Josh Uhr, MD,
Editorially Independent content supported by Regeneron.
08.22.24
ASRS ’24: PAVILION at 100 WeeksMargaret Chang, MD
Editorially Independent content supported by Genentech.
08.08.24
ASRS ’24: ACP in Patients with Major EZ Attenuation, and GALE Microperimetry FindingsKatherine Talcott, MD; and Sunir Garg, MD
Editorially Independent content supported by Genentech.
07.19.24
New Retina Radio Journal Club w/ VBS: Risk Factors for Switching from Bevacizumab to Aflibercept in Protocol ACRebecca Soares, MD; Matt Starr, MD; and Nikisha Kothari, MD
Editorially Independent content supported by Genentech.
07.11.24
From Trials to the Clinic: Using a Therapy With a Novel MOA to Treat Patients With DMEJohn Kitchens, MD and Maria Berrocal, MD
Sponsored by Genentech.
06.27.24
New Retina Radio Journal Club w/ VBS: RVOs During the COVID PandemicKatherine Talcott, MD; Phoebe Mellen, MD and Kyle Kovacs, MD
Editorially Independent content supported by Genentech.
06.20.24
A Treatment With a Novel MOA for Patients With nAMD and DME: Perspectives From the Real WorldJohn Kitchens, MD; Margaret Chang, MD, MS; and David S. Chin Yee, MD
Sponsored by Genentech.
06.17.24
AMD and DME Applications in the Retina Practice: Real-world DataPaul Hahn, MD, PhD; Durga Borkar, MD, MMCi; and Ted Leng, MD
Editorially independent content supported by Genentech.
06.05.24
ARVO 2024 Coverage: UWF Leakage in Protocol AA, Machine Learning, and GA's Link to Anxiety/DepressionJustis Ehlers, MD; and Lisa Faia, MD
Editorially Independent content supported by Genentech.
05.29.24
New Retina Radio Journal Club with VBS: Is Buckling Effective for RRD in Patients at Risk for PVR?David Xu, MD; Barton Blackorby, MD; and Prethy Rao, MD, MPH
Editorially Independent content supported by Genentech.
05.17.24
ARVO 2024 Coverage: ≥20-week Dosing in PULSAR and TENAYA/LUCERNEPhilip Storey, MD; and Prof. Sobha Sivaprasad
Editorially Independent content supported by Genentech.
05.10.24
GA Options in Clinical Therapy, Part 2: Real-World Cases in GADavid RP Almeida, MD, PhD, MBA; Lisa Faia, MD; and Chris Riemann, MD
Editorially Independent content supported by Astellas.
05.10.24
GA Options in Clinical Therapy, Part 1: Patient Selection and Treatment StrategiesDavid RP Almeida, MD, PhD, MBA; Lisa Faia, MD; and Chris Riemann, MD
Editorially Independent content supported by Astellas.
05.08.24
AMD and DME Applications in the Retina Practice: RCT ComparisonPaul Hahn, MD, PhD; Durga Borkar, MD, MMCi; and Ted Leng, MD
04.25.24
The State of Biosimilars: Integration of Biosimilars into a Retina PracticeJohn W. Kitchens, MD (Moderator); David Brown, MD; and Kristin Yockus
Editorially Independent content supported by Sandoz.
04.19.24
New Retina Radio Journal Club with VBS: Comparison of Antiseptics Use for IVTSruthi Arepalli, MD; Vaidehi Dedania, MD; and Rebecca Soares, MD, MPH
Editorially Independent content supported by Genentech.
04.02.24
Successful Management of Vitreous OpacitiesJohn Kitchens, MD, Edwin H. Ryan, MD, Christina Y. Weng, MD, MBA, and Alison Bozung, OD
Editorially Independent content supported by Alcon.
03.28.24
New Retina Radio Journal Club with VBS: Visual Outcomes Following Surgical RRD Repair Relative to Foveal Status and Time of SurgeryLediana Goduni, MD, Matt Starr, MD, and Joshua Uhr, MD
Editorially Independent content supported by Genentech.
03.01.24
Treating Geographic Atrophy (GA) In Your PracticeEsther Kim, MD; John W. Kitchens, MD; and Scott Walter, MD
Sponsored by Apellis Pharmaceuticals, Inc.
03.01.24
Diagnosing Geographic Atrophy (GA) and Identifying Eligible Patients For TherapyEsther Kim, MD; John W. Kitchens, MD; and Scott Walter, MD
Sponsored by Apellis Pharmaceuticals, Inc.
02.22.24
The State of Biosimilars: How We Got Here and What It Means for PracticeJohn Kitchens, MD; Carl Awh, MD; Firas Rahhal, MD
Editorially Independent content supported by Sandoz.
02.16.24
Cherchez la Femme RevisitedAn interview with Julia A. Haller, MD. By Adrienne W. Scott, MD, and Steven Sanislo, MD
12.14.23
AAO ’23: Downward Trends in Reimbursement and ChatGPT in the Retina ClinicJohn Thompson, MD and Raymond Iezzi, MD
Editorially Independent content supported by Genentech.
12.07.23
New Retina Radio Journal Club: Intentional Suspension of Therapy in Wet AMDSruthi Arepalli, MD, Rebecca Soares, MD, MPH, and Vaidehi Dedania, MD
Editorially Independent content supported by Coherus.
11.30.23
AAO ’23: Real-World Faricimab Patterns and Improving GA AssessmentsSophie Bakri, MD; and Karl Csaky, MD, PhD
Editorially Independent content supported by Genentech.
11.22.23
New Retina Radio AAO Late-Breakers: PULSAR at 96 Weeks and Home OCT in Wet AMDJean-François Korobelnik, MD, PhD; and W. Lloyd Clark, MD
Editorially Independent content supported by Genentech.
11.21.23
New Retina Radio Journal Club: Prophylactic Laser for Lattice Degeneration in Fellow Eyes After RRD RepairEditorially Independent content supported by Genentech.
11.13.23
New Retina Radio AAO Late-Breakers: ALTITUDE and DIAMONDMark Barakat, MD; and And Hani Salehi-Had, MD
Editorially Independent content supported by Genentech.
10.26.23
New Retina Radio Journal Club: Are Postpartum Retinal Detachment Rates Linked to Method of Delivery?Lediana Goduni, MD, Matt Starr, MD, and Joshua Uhr, MD
Editorially Independent content supported by Coherus.
10.05.23
Chronic Postoperative Inflammation: Patient ScenariosJohn Kitchens, MD; Brian Do, MD; and Katherine Talcott, MD
Editorially Independent content supported by Alimera Sciences, Inc..
09.28.23
New Retina Radio Journal Club: Cost Evaluation in DME TherapyPriya Vakharia, MD, Sruthi Arepalli, MD, and Vaidehi Dedania, MD
Editorially Independent content supported by Genentech.
09.28.23
New Retina Radio Journal Club: Cost Evaluation in DME TherapyPriya Vakharia, MD, Sruthi Arepalli, MD, and Vaidehi Dedania, MD
Editorially Independent content supported by Genentech.
09.25.23
How Imaging Helps Clinics Integrate New Therapies in GAAleksandra Rachitskaya, MD; Mrinali Gupta, MD; and Katherine Talcott, MD
Supported by ZEISS Professional Education
09.22.23
Luminaries in Retina: Kirk Packo, MD, FACS (Part 2)John Kitchens, MD; and Kirk Packo, MD, FACS
09.22.23
Luminaries in Retina: Kirk Packo, MD, FACS (Part 1)John Kitchens, MD; and Kirk Packo, MD, FACS
09.21.23
Chronic Postoperative Inflammation: Steroids’ Role in TreatmentJohn Kitchens, MD; Vaidehi Dedania, MD; and David Eichenbaum, MD
Editorially Independent content supported by Alimera Sciences, Inc.
09.07.23
New Retina Radio Journal Club: Meta-analysis of PPV for Diabetic TRDKatherine Talcott, MD, Kyle Kovacs, MD, and Rebecca Soares, MD, MPH
09.01.23
ASRS ’23: Pegcetacoplan Extension Study, and Comparison of Pegcetacoplan and Avacincaptad PegolNathan C. Steinle, MD; and Paul Hahn, MD, PhD
Editorially Independent content supported by Genentech.
08.25.23
Chronic Postoperative Inflammation: Initial EncountersJohn Kitchens, MD; Lisa Faia, MD; and Daniel Kiernan, MD
Editorially Independent content supported by Alimera Sciences, Inc.
08.22.23
Imaging Geographic Atrophy: OCT, FAF, NIR, and OCTARishi P. Singh, MD; Roger A. Goldberg, MD, MBA; Mrinali Gupta, MD; Katherine Talcott, MD
Sponsored by ZEISS
08.11.23
ASRS ’23: Missed Injections for AMD/DME/RVO and Anatomic Response to Vabysmo in Wet AMDChristina Y. Weng, MD, MBA; and Nikolas JS London, MD
Editorially Independent content supported by Genentech.
07.20.23
New Retina Radio Journal Club: Is Software on Home OCT as Good as Human Graders?Sabin Dang, MD, Lediana Goduni, MD, and Prethy Rao, MD, MPH
Editorially Independent content supported by Genentech.
05.25.23
New Retina Radio Journal Club: Wet AMD: Fluid-free Visits' Association with Anatomic and Visual OutcomesKatherine Talcott, MD; Kyle Kovacs, MD; and Rebecca Soares, MD, MPH
Editorially Independent content supported by Genentech.
05.18.23
New Retina Radio ARVO Coverage: DME Update: 8-mg Aflibercept data and Faricimab TAE in Phase 3Diana Do, MD; and Jennifer Lim, MD
Editorially Independent content supported by Genentech.
05.11.23
New Retina Radio ARVO Coverage: Faricimab in Wet AMD: Real-world and Phase 3 DataDurga Borkar, MD, MMCi and Varun Chaudhary, MD
Editorially Independent content supported by Genentech.
05.03.23
Treating GA In Your ClinicAllen C. Ho, MD; Robert L. Avery, MD; Eleonora M. Lad, MD, PhD; Jeffrey S. Heier, MD; and Dilsher Dhoot, MD
04.20.23
New Retina Radio Journal Club: AMD and Depression RiskSabin Dang, MD; Lediana Goduni, MD; and Prethy Rao, MD, MPH
Editorially Independent content supported by Genentech.
03.28.23
New Retina Radio Journal Club: Duration of Macular Detachment and Final Visual PrognosisPriya Vakharia, MD; Sruthi Arepalli, MD; and Vaidehi Dedania, MD
Editorially Independent content supported by Genentech.
03.27.23
The Utility of OCTA in the Clinic02.13.23
Inclusion Pearls and Pitfalls For Retina SpecialistsVivienne S. Hau, MD, PhD; Basil K. Williams Jr, MD; Jessica Weinstein, MD; Roberto Diaz-Rohena, MD; Steven Sanislo, MD; and Brandon Johnson, MD
12.29.22
Tips for Mastering Secondary IOLsChristina Y. Weng, MD, MBA; Ashkan M. Abbey, MD; María H. Berrocal, MD; and Omesh P. Gupta, MD, MBA
12.15.22
New Retina Radio Journal Club: Profiling Punctate Inner Choroidopathy-like ReactionsYasha Modi, MD; Kyle Kovacs, MD; and Priya Vakharia, MD
12.09.22
AAO '22: Biosimilars’ Practice Implications and Year 2 of YOSEMITE/RHINEGeorge Williams, MD, and Caroline Baumal, MD
Editorially Independent content supported by Genentech.
12.05.22
Innovations in Retinal ImagingJohn Kitchens, MD; Aleksandra Rachitskaya, MD; and Jonathan Russell, MD, PhD
12.01.22
AAO '22 Late-Breaking Talks: Gene Therapies for GA and XLRPMichel Michaelides, BSc, MB, BS MD(Res), FRCOphth; and Jeffrey Heier, MD
Editorially Independent content supported by Genentech.
11.17.22
New Retina Radio Journal Club: Biosimilars in Retina: A Pair of Phase 3 PapersYasha Modi, MD; Kyle Kovacs, MD; and Priya Vakharia, MD
11.10.22
AAO '22: Biomarkers and AI in the ORJoan Miller, MD; and Yannek Leiderman, MD, PhD
Editorially Independent content supported by Genentech.
11.03.22
AAO '22 Late-Breaking Talks: Biosimilar Phase 3 Data and TRUCKEE UpdateAnat Loewenstein, MD; and Ramanath Bhandari, MD
Editorially Independent content supported by Genentech.
10.25.22
AAO '22: GATHER2 Study ResultsArshad Khanani, MD, MS
Editorially Independent content supported by Genentech.
10.13.22
New Retina Radio Journal Club: Latest Literature in Stickler Syndrome and GRTsYoshi Yonekawa, MD, PhD; Peter Campbell, MD; Karen Jeng-Miller, MD; and Prethy Rao, MD
09.30.22
New Retina Radio Journal Club: Updates in ROPYoshihiro Yonekawa, MD, PhD; Peter Campbell, MD; Karen Jeng-Miller, MD; and Prethy Rao, MD
09.15.22
ASRS Meeting Coverage Day 3: DR Biomarkers and Gene Tx for AchromatopsiaJennifer Lim, MD; and Lejla Vajzovic, MD
Editorially Independent content supported by Genentech.
08.25.22
New Retina Radio Journal Club: Multifocal, Indolent, Nonprogressive Choroidal LesionsKyle Kovacs, MD; Cynthia Qian, MD; and David Xu, MD
08.04.22
ASRS Meeting Coverage Day 2: Diabetic Eye Disease UpdatesJohn Kitchens, MD; and Michael Allingham, MD, PhD
Editorially Independent content supported by Genentech.
07.28.22
ASRS Meeting Coverage Day 1: TALON and TRUCKEE in Wet AMDCarl Regillo, MD; and Carl Danzig, MD
Editorially Independent content supported by Genentech.
07.14.22
New Retina Radio Journal Club: Recurrent RRD ManagementKyle Kovacs, MD; Cynthia Qian, MD; David Xu, MD
06.30.22
Luminaries in Retina: The Life and Career of Steve Charles, MD, FACS, FICS, FASRSJohn W. Kitchens, MD; and Steve Charles, MD, FACS, FICS, FASRS
06.23.22
New Retina Radio Journal Club: Pentosan Polysulfate MaculopathyBasil Williams, MD; Karen Jeng-Miller, MD, MPH; M. Ali Khan, MD; and Katherine Talcott, MD
06.09.22
ARVO Meeting Coverage Day 3: CANDELA and ARCHWAY DataDavid Brown, MD and Robert Mittra, MD
Editorially Independent content supported by Genentech.
06.02.22
ARVO Meeting Coverage Day 2: Pipeline Therapies in GAAllen C. Ho, MD and Jared Nielsen, MD, MBA
Editorially Independent content supported by Genentech.
05.26.22
ARVO Meeting Coverage Day 1: LIGHTSITE III and DERBY/OAKS at 18 MonthsEditorially Independent content supported by Genentech.
05.19.22
New Treatment Options and Considerations for AMDAllen C. Ho, MD; Robyn Guymer AM, MBBS, PhD, FRANZCO, FAHMS; Charles C. Wykoff, MD, PhD; and Diana V. Do, MD
05.12.22
New Retina Radio Journal Club: Trends in Retina ReimbursementEric Nudleman, MD, PhD; John Miller, MD; Thanos Papakostas, MD; and Priya Vakharia, MD
04.21.22
New Retina Radio Journal Club: Diversity in Clinical TrialsBasil Williams, MD; Karen Jeng-Miller, MD, MPH; M. Ali Khan, MD; and Katherine Talcott, MD
03.31.22
New Retina Radio Journal Club: PPV vs PnR for RRDEric Nudleman, MD, PhD; John Miller, MD; Thanos Papakostas, MD; and Priya Vakharia, MD
03.24.22
Art of Drug Choice: Treating New Wet AMD PatientsArshad M. Khanani, MD, MA; Lejla Vajzovic, MD, and Joseph M. Coney, MD
Editorially Independent content supported by Novartis & Alcon.
03.17.22
Art of Drug Choice: Who Is Best Suited for Extended-duration Therapy?Arshad M. Khanani, MD, MA; Lejla Vajzovic, MD; and Joseph M. Coney, MD
Editorially Independent content supported by Novartis & Alcon.
03.03.22
Art of Drug Choice: The Latest Advances in Wet AMD TherapyArshad M. Khanani, MD, MA; Lejla Vajzovic, MD, and Joseph M. Coney, MD
Editorially Independent content supported by Novartis & Alcon.
02.24.22
Anti-VEGF, A Biography: Part 3John D. Pitcher III, MD; Bob Avery, MD; David Brown, MD; Jeffrey Heier, MD; Nancy Holekamp, MD; Kirk Packo, MD; Phillip Rosenfeld, MD, PhD; and Bob Vitti, MD
02.17.22
Anti-VEGF, A Biography: Part 2John D. Pitcher III, MD; Bob Avery, MD; Dave Brown, MD; Anne Fung, MD; Jeffrey Heier, MD; Andrew Moshfeghi, MD, MBA; Kirk Packo, MD; and Philip Rosenfeld, MD, PhD
02.11.22
Exploring the clinical development program for an innovative, continuous delivery treatment for nAMDJohn Kitchens, MD and Dante Pieramici, MD
02.03.22
Tackling PVR in the ORAllen C. Ho, MD; Robert L. Avery, MD; Dean Eliott, MD; Avni P. Finn, MD, MBA; Ajay Kuriyan, MD, MS; and M. Ali Khan, MD
01.27.22
Anti-VEGF, A Biography: Part 1John D. Pitcher III, MD; Tony Adamis, MD; Bob Avery, MD; Jeff Heier, MD; and Kirk Packo, MD
01.18.22
Perspectives on an innovative drug delivery system for nAMD: From training to initial experiences01.04.22
Matching Patients to Therapy in Wet AMD: Lifestyle Factors That Guide TreatmentJohn Kitchens, MD; Murtaza Adam, MD; and Aleksandra Rachitskaya, MD
12.22.21
Matching Patients to Therapy in Wet AMD: Deciding Who Is Best Suited for Long-Duration TreatmentsJohn Kitchens, MD; Lisa Faia, MD; and Sumit Sharma, MD
12.14.21
Matching Patients to Therapy in Wet AMD: How New Technology May Alleviate Treatment BurdenJohn Kitchens, MD; Carl Regillo, MD; and Adrienne Scott, MD
12.10.21
New Retina Radio Journal Club: Medical Management of Macular HolesChristina Weng, MD, MBA; Brian Do, MD; Mrinali Gupta, MD; and Dmitra Skondra, MD, PhD,
12.03.21
PALADIN for DME and ROP Updates From the ICROPMichael Singer, MD; and R.V. Paul Chan, MD, MSc, MBA
11.26.21
New Retina Radio Journal Club: Biosimilars in Wet AMDAleksandra Rachitskaya, MD; Emmanuel Chang, MD, PhD; Michael Klufas, MD; and Dmitra Skondra, MD
11.12.21
International Perspectives on ROPProf. Andreas Stahl, Dr. Maria Ana Martinez-Castellanos, Silke Mader
11.09.21
Luminaries in Retina: Kirk Packo, MD, FACS (Part 2)John W. Kitchens, MD; Kirk Packo, MD, FACS
11.09.21
Luminaries in Retina: Kirk Packo, MD, FACS (Part 1)John W. Kitchens, MD; Kirk Packo, MD, FACS
11.05.21
ASRS 2021 Coverage: The Pipeline for Wet AMD and GAMark Barakat, MD; and Nancy Holekamp, MD
10.29.21
ASRS 2021 Coverage: Losing GA Patients to Follow-up and DME Meta-analysisDurga Borkar, MD; and M. Ali Khan, MD
10.19.21
Vitreous Opacities: How ODs and MDs Can CollaborateJohn Kitchens, MD; Tarek Hassan, MD; and Walt Whitley, OD, MBA
10.15.21
New Retina Radio Journal Club: Treating CMV with Adoptive ImmunotherapyChristina Weng, MD, MBA; Mrinali Gupta, MD; Brian Do, MD; and Dimitra Skondra, MD, PhD
10.08.21
International Perspectives: RVOJennifer Arnold, MD; Ramin Tadayoni, MD; and Armin Wolf, MD
10.01.21
Vitreous Opacities: Hearing from Anterior and Posterior Segment SurgeonsJohn Kitchens, MD; María Berrocal, MD; and Elizabeth Yeu, MD
09.17.21
New Retina Radio Journal Club: Exudative AMD in FILLY and GATHER1 ResultsAleksandra Rachitskaya, MD; Emmanuel Chang, MD, PhD; Michael Klufas, MD; and Dmitra Skondra, MD
09.10.21
The Art of Drug Choice: International Panel in Wet AMD: Safety DataArshad M. Khanani, MD; Justus G. Garweg, MD; Seenu M. Hariprasad, MD; Peter Kertes, MD, FRCSC
09.03.21
Vitreous Opacities: Innovations and the Decision to OperateJohn Kitchens, MD; S.K. Steven Houston III, MD; Christina Weng, MD, MBA
09.01.21
The Art of Drug Choice: International Panel in Wet AMD: The PipelineArshad M. Khanani, MD; Justus G. Garweg, MD; Seenu M. Hariprasad, MD; Peter Kertes, MD, FRCSC
08.27.21
International Perspectives: DMEPatricio Schlottmann; Catherine Creuzot-Garcher; and Adnan Tufail
08.20.21
The Art of Drug Choice: International Panel in Wet AMD: Phase 3 and Real-World Data to WatchArshad Khanani, MD, MA; Justus Garweg, MD; Seenu Hariprasad, MD; Peter Kertes, MD, FRCSC
08.13.21
New Retina Radio Journal Club: Data in the Wake of COVID-19Caroline Baumal, MD; M. Ali Khan, MD; Vlad Matei, MD; Christina Weng, MD, MBA
08.06.21
The Art of Drug Choice: International Panel in Wet AMD: When and Why Switching Therapy Makes SenseArshad M. Khanani, MD, MA; Justus G. Garweg, MD; Seenu M. Hariprasad, MD; and Peter Kertes, MD, FRCSC
07.29.21
Surgical options for treating AMD: Clinical Implications and ImpactCarl D. Regillo, MD; Carl Awh, MD; and Dante Pieramici, MD
07.26.21
Advances in Gene Therapy for Wet AMDAllen C. Ho, MD; Robert L. Avery, MD; Peter Campochiaro, MD, PhD; Jeffrey S. Heier, MD; Szilárd Kiss, MD; and Charles Wykoff, MD, PhD
07.16.21
New Retina Radio Journal Club: Masking in Retina: Keeping Patients Safe from Bacterial ExposureYoshihiro Yonekawa, MD; Jonathan Chang, MD; Ajay Kuriyan, MD; and Paula Pecen, MD
07.09.21
Reconsidering treatment endpoints in real-world clinical practice: is achieving a favorable retreatment interval a goal of therapy?Carl D. Regillo, MD; Jennifer Lim, MD; and Charles Wykoff, MD, PhD
06.25.21
New Retina Radio Journal Club: Autologous Retina Transplant for Macular HolesCaroline Baumal, MD; M. Ali Khan, MD; Vlad Matei, MD; and Christina Weng, MD, MBA
06.11.21
Real-world impact of patients lost to follow-up: factors that drive nonadherence and strategies for encouraging better follow-up from patientsCarl D. Regillo, MD; Margaret Chang, MD; and David Eichenbaum, MD
05.21.21
ARVO 2021 Coverage: TENAYA/LUCERNE Results—and Is Fluid OK in Wet AMD?Arshad Khanani, MD, MA; and David Lally, MD
05.14.21
New Retina Radio Journal Club: Protocol W: How Might the Data Change Practice?Yoshihiro Yonekawa, MD; Ajay Kuriyan, MD; Anton Orlin, MD; and Paula Pecen, MD
04.15.21
New Retina Radio Journal Club: PRO Study Group Papers: Part 2Jay Sridhar, MD; Brian Do, MD; Sabin Dang, MD; and Avni Finn, MD, MBA
03.30.21
New Retina Radio Journal Club: PRO Study Group Papers: Part 1Jay Sridhar, MD; Brian Do, MD; Sabin Dang, MD; and Avni Finn, MD, MBA
03.08.21
New Retina Radio Journal Club: OCT Biomarkers in New Onset GAYoshihiro Yonekawa, MD; Marion Munk, MD, PhD; Lejla Vajzovic, MD; and David Xu, MD
03.04.21
Angiogenesis 2021: Geographic AtrophyJohn Kitchens, MD; Pravin Dugel, MD, and SriniVas Sadda, MD
03.01.21
Let’s Talk Diversity and Inclusion02.25.21
New Retina Radio Journal Club: Anti-VEGF vs Surgery + PRP for VH with PDRAleksandra Rachitskaya, MD; Mrinali Gupta, MD; Eric Nudleman, MD, PhD; and Aris Thanos, MD
02.10.21
New Retina Radio Journal Club: Phase 2 LADDER Study DataAleksandra Rachitskaya, MD; Mrinali Gupta, MD; Eric Nudleman, MD, PhD; and Aris Thanos, MD
02.08.21
International Perspectives: Digital Solutions for the Management of AmblyopiaProf. Richard Harrad; Prof. Ben Thompson; and Prof. Ann Webber
01.28.21
International Perspectives: How Will Artificial Intelligence Affect the Practice of Ophthalmology?Dr Peter Kaiser; Prof. James Wolffsohn; and Dr Pearce Keane
01.25.21
Clinical Impacts From AAO 2020: Drs. Singh, Ehlers, and GilliesRishi Singh, MD; Justis Ehlers, MD; and Mark Gillies, MD, PhD
01.20.21
International Perspectives: Fluid in Neovascular Age-Related Macular Degeneration – Evolution of UnderstandingRishi Singh; Jennifer Arnold; Mark Gillies; and SriniVas Sadda
01.08.21
New Retina Radio Journal Club: Imaging Modalities in DRJorge Fortun, MD; Cynthia Qian, MD; Christina Weng, MD, MBA; and Basil Williams, MD
12.21.20
New Retina Radio Journal Club: Intravitreal Dexamethasone Implant in DME PatientsJorge Fortun, MD; Cynthia Qian, MD; Christina Weng, MD, MBA; and Basil Williams, MD
12.17.20
Clinical Impacts From AAO 2020: Drs. Singh, Do, and HeierRishi Singh, MD; Diana Do, MD; and Jeffrey Heier, MD
11.19.20
The Art of Drug Choice: Wet AMD and the Latest DataArshad M. Khanani, MD, MA; Christopher G. Fuller, MD; Nikolas J.S. London, MD, FACS; and Christina Y. Weng, MD, MBA
11.19.20
The Art of Drug Choice: Phase 3 Trials in Wet AMDArshad M. Khanani, MD, MA; Christopher G. Fuller, MD; Nikolas J.S. London, MD, FACS; and Christina Y. Weng, MD, MBA
11.19.20
The Art of Drug Choice: Wet AMD PipelineArshad M. Khanani, MD, MA; Christopher G. Fuller, MD; Nikolas J.S. London, MD, FACS; and Christina Y. Weng, MD, MBA
11.19.20
The Art of Drug Choice: Safety in Wet AMDArshad M. Khanani, MD, MA; Christopher G. Fuller, MD; Nikolas J.S. London, MD, FACS; and Christina Y. Weng, MD, MBA
11.10.20
New Retina Radio Journal Club: Putting the Fun Back in Journal ClubJohn Kitchens, MD; Jorge Fortun, MD; Cynthia Qian, MD; Christina Weng, MD, MBA; and Basil Williams, MD
10.30.20
International Perspectives: Clinical considerations for optimal management of patients with IRDsProf. Bart Leroy; Prof. Isabelle Audo; and Prof. Robert Maclaren
10.16.20
Back to Practice: Combating Patient Misinformation Regarding COVID-19John W. Kitchens, MD; Patricio Schlottmann, MD; Nicole Eter, MD; and Adnan Tufail, MBBS, MD, FRCOphth
10.15.20
Back to Practice: Telemedicine & Combating Patient MisinformationJohn Kitchens, MD; Judy E. Kim, MD; Byron Ladd, MD; and Carl D. Regillo, MD
10.03.20
Back to Practice: Telemedicine in the COVID-19 EraJohn W. Kitchens, MD; Francesco Boscia, MD; David Steel, MBBS, FRCOphth; and Ramin Tadayoni, MD, PhD
10.01.20
Back to Practice: Academic Settings in a Pandemic: Rules and RegulationsJohn Kitchens, MD; Dilraj Grewal, MD; Adrienne Scott, MD; and Elliott Sohn, MD
09.16.20
Back to Practice: Educating the Next Generation of Surgeons During COVID-19John Kitchens, MD; Sophie Bakri, MD; Julia Haller, MD; and R.V. Paul Chan, MD, MSc, MBA
08.28.20
Back to Practice: What Happens During a COVID-19 Resurgence?John W. Kitchens, MD; Steve Charles, MD; Amy Schefler, MD; and Jayanth Sridhar, MD
08.26.20
Back to Practice: Technology and COVID-19: Necessity Is the Mother of InventionJohn W. Kitchens, MD; María H. Berrocal, MD; Jean-Francois Korobelnik, MD, PhD; and Manish Nagpal, MBBS, MS, FRCS
08.03.20
Back to Practice: COVID-19 Clinical and Surgical Protocols: Which Changes Are Here to Stay?John W. Kitchens, MD; Marí a Ana Castellanos-Martinez, MD; and Matteo Forlini, MD
07.30.20
Back to Practice: Education as In-Person Meetings Are PausedJohn W. Kitchens, MD; Anat Loewenstein, MD; and Timothy G. Murray, MD, MBA
08.28.17
Beyond the Walls of ORs and Borders of NationsDon D'Amico, MD, R.V. Paul Chan, MD, and Pravin Dugel, MD
02.24.17
Alphabet Soup: PhD, MBA, JD, MSDerek Kunimoto, MD, JD; Paul Hahn, MD, PhD; David Almeida, MD, PhD, MBA; and Scott Walter, MD, MS.
12.28.16
Je Ne Sais QuoiJulia Haller, MD; Anat Loewenstein, MD; Geeta Lalwani, MD; Jessica Randolph, MD; and Talisa de Carlo, MD
11.16.16
Ophthalmologist BarbieJulia Haller, MD; Anat Loewenstein, MD; Jessica Randolph, MD; and Talisa de Carlo, MD
Show More
